Viewing Study NCT05441956


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2025-12-25 @ 9:16 PM
Study NCT ID: NCT05441956
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-18
First Post: 2022-06-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor: Shenzhen TargetRx, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module